With substantial progress in developing its differentiated and innovative CGM and its significant market potential, Trinity Biotech’s board and management have determined that CGM technology and ...

Trinity Biotech (TRIB) announces the next stage in realizing its comprehensive transformation plan and development of its continuous glucose ...

Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a CGM to market.

Trinity Biotech, a commercial-stage biotech company focused on human diagnostics and diabetes management solutions, including wearable biosensors, has appointed Barclays Capital as its exclusive finan ...

The stock has a market cap of $12.48 million, a PE ratio of -0.31 and a beta of 1.20. Trinity Biotech has a twelve month low of $0.63 and a twelve month high of $3.55. An institutional investor ...

DUBLIN, Ireland, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions ...

Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

What the Catechism of the Catholic Church says on "The Trinity:" 232. "Christians are baptized 'in the name of the Father and of the Son and of the Holy Spirit' [Mt 28:19.] Before receiving the ...

After hours: March 11 at 7:55:18 PM EDT Loading Chart for TRIB ...